How will I know if my Prostate Cancer treatment is working

How to Know If Your Prostate Cancer Treatment Is Working

This is one of the most important questions you can ask, and the answer involves multiple types of monitoring rather than relying on just one measure. Let me walk you through how your medical team will assess treatment effectiveness.

The Main Monitoring Tools

1. PSA (Prostate-Specific Antigen) Levels

PSA is a protein produced by the prostate, and it's the primary marker doctors track. Here's what to expect:

• What it measures: PSA levels in your blood typically rise when prostate cancer is present or progressing
• What "working" looks like: A declining PSA trend suggests your treatment is having an effect
• Important caveat: PSA alone doesn't tell the whole story

According to the CancerPatientLab webinar on Bipolar Androgen Therapy, PSA is a "rough marker" and shouldn't be your only measure of success. Here's why this matters:

"Sometimes PSA will increase but cancer scans show no growth or even regression. Along those lines, sometimes increased bone metastasis activity appears to occur for about 2-3 months before drastic reductions in activity are seen."

This means your PSA might go up initially while your cancer is actually responding—a phenomenon called a "flare" that can be confusing if you're not expecting it.

2. Imaging Scans

Your doctor will use various scans to visualize your cancer and see if tumors are shrinking or stable:

Types of scans used:

• Bone scans (using Technetium-99m tracer) - important because 70-80% of men with metastatic castration-resistant prostate cancer have bone metastases
• PSMA-PET scans (Prostate-Specific Membrane Antigen imaging) - a newer, highly specific scan that highlights prostate cancer cells
• FDG-PET scans (Fluorodeoxyglucose imaging) - shows areas of high glucose activity

What to watch for: Shrinking tumors, stable disease (no growth), or disappearing lesions indicate treatment is working.

Important: Be aware of "bone scan flare"—your scans might look worse before they look better. According to the webinar, this can happen in the first 2-3 months of treatment, where bone lesions appear darker or new spots appear, but your PSA is actually dropping. This is a sign of response, not progression, though it can be confusing.

3. Clinical Symptoms and Quality of Life

How you feel matters significantly:

• Energy levels: Are you less fatigued?
• Pain: Is bone pain or other cancer-related pain improving?
• Functional ability: Can you do more activities?
• Side effects: Are treatment side effects manageable?

According to the webinar discussion, even if your PSA plateaus (stops rising) without dropping, this can be a "win-win" if your quality of life improves during that time. Stabilizing your disease while maintaining good quality of life is considered a beneficial response.

Understanding Different Response Patterns

Research shows that patients respond in roughly three ways:

1. Good Response (About 1/3 of patients)

• PSA drops significantly
• Scans show tumor shrinkage
• This is the most obvious sign of treatment working

2. Stable Disease (About 1/3 of patients)

• PSA plateaus or rises slowly
• Scans show no growth or minimal growth
• Cancer isn't progressing, which is still a meaningful benefit
• Quality of life may improve during this period

3. No Benefit (About 1/3 of patients)

• PSA continues rising
• Scans show progression
• May need to switch treatments

Important Timing Considerations

Don't panic if PSA rises initially. According to the webinar: "If PSA increases for 1-2 cycles, do not panic. PSA often increases before it starts going down."

This is especially true with certain treatments. Your doctor needs time to assess whether:

• Your cancer is truly progressing, OR
• You're experiencing an initial flare that precedes a good response

This is why scans and clinical symptoms are preferred alongside PSA monitoring—they give a more complete picture.

Additional Monitoring Tools

Your doctor may also use:

• Liquid biopsies: Blood tests that detect circulating tumor DNA or other cancer markers
• Genetic testing: Tests like Foundation One can identify mutations that predict treatment response
• RECIST criteria: A standardized way to measure whether tumors have shrunk, stayed the same, or grown

Questions to Ask Your Oncologist

To stay informed about your treatment response, ask:

1. "What is my baseline PSA, and what PSA level would indicate the treatment is working?"
2. "How often will we check my PSA and imaging, and what changes would prompt us to switch treatments?"
3. "If my PSA goes up initially, how will you determine if that's a flare or true progression?"
4. "What do my recent scans show compared to my previous scans?"
5. "Are there any genetic tests or liquid biopsies that would help predict my response to this specific treatment?"

The Bottom Line

Treatment is working when you see a combination of:

• Declining or stable PSA
• Stable or shrinking tumors on scans
• Stable or improving symptoms and quality of life
• Absence of new metastases (cancer spread)

Your oncologist will look at all these factors together, not just one number. If you're not seeing improvement across multiple measures after a reasonable treatment period, that's when your team will discuss alternative approaches.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about your specific treatment plan and response monitoring.